Protein complex in bacterial cell membrane acts like a rotary motor to recruit DNA-degrading enzymes to defend against phage ...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central ...

Gilead Sciences Inc. sees 2025 earnings rising faster than Wall Street expected after a big fourth-quarter beat highlighted ...

Global genital herpes treatment market will reach $5,051.8 million by 2032, growing by 4.7% annually over 2022-2032, driven by the rising prevalence of sexually transmitted diseases, changing ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 35 tables and 45 figures, this 111-page report ?Europe Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, ...

Virpax Pharmaceuticals, Inc. ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) ...

Study Shows Drop in Use of Antiviral Medications in Young Children ... two-step flu vaccination strategy that pairs intramuscular injection of a viral vectored flu vaccine with nasal spray ...

Sep. 3, 2024 — Starting antiviral treatment as late as 14 days ... two-step flu vaccination strategy that pairs intramuscular injection of a viral vectored flu vaccine with nasal spray ...

A generation has passed since the world saw the peak in AIDS-related deaths. Those deaths — agonizing, from diseases the body ...

Two sexually transmitted infections are spreading faster than ever. Our expert guide tells you everything you need to know, ...

In 2023, non-benefit medical expenses for flu shots, which are not covered by insurance, exceeded 300 billion won, five times larger than before the coronavirus pandemic. This is attributed to an ...

The abrupt stop work order at the USAID has left thousands in medical danger, requiring doctors to weigh their ethics against ...